Ismo
Ismo
- In our pharmacy, you can buy ismo (isosorbide mononitrate) without a prescription, with delivery across Canada and discreet packaging; note that in many countries isosorbide mononitrate is officially prescription-only.
- Ismo is used to prevent angina pectoris (stable angina). It is an organic nitrate that releases nitric oxide, causing vasodilation (especially venodilation), reducing cardiac preload and myocardial oxygen demand.
- The usual dose is 20 mg once or twice daily for immediate‑release tablets; extended‑release doses are commonly 40–60 mg once daily. Doses may be titrated per response, with care to avoid tolerance.
- Ismo is given orally as tablets—immediate‑release (e.g. 10 mg, 20 mg) and extended‑release/retard formulations (e.g. 40 mg, 50 mg, 60 mg).
- The effect typically begins within about 30–60 minutes for immediate‑release tablets (extended‑release formulations may take 1–2 hours to start working).
- Duration of action is approximately 4–6 hours for immediate‑release formulations and about 12–24 hours for extended‑release formulations; a daily nitrate‑free interval of ~10–12 hours is recommended to prevent tolerance.
- Avoid alcohol while taking ismo, as alcohol can worsen blood‑pressure lowering effects and increase the risk of dizziness or fainting.
- The most common side effect is headache (so‑called “nitrate headache”).
- Would you like to try ismo without a prescription?
Basic Ismo Information
- INN (International Nonproprietary Name): Monoket is the brand name; its INN is isosorbide mononitrate.
- Brand Names Available In Canada (English): not specified
- ATC Code: C01DA14
- Forms & Dosages: Oral immediate-release tablets 10 mg and 20 mg; extended-release tablets 40 mg, 50 mg, 60 mg; common packages include blisters and bottles (20, 28, 30, 60, 100 tablets).
- Manufacturers In Canada (English): not specified
- Registration Status In Canada (English): not specified
- OTC / Rx Classification: Prescription Only (Rx) in major markets; not available as OTC.
Availability & Price Landscape
Major National Pharmacy Chains (Shoppers Drug Mart, Rexall, London Drugs)
Canadians usually find isosorbide mononitrate stocked at community pharmacy chains and in some independents.
Shoppers Drug Mart, Rexall and London Drugs commonly dispense nitrates through prescription ordering and provincial reimbursement pathways.
Jean Coutu serves Quebec patients and may stock particular brands or import generics per distributor contracts.
Specific brand and strength availability (for example IR 10 mg and 20 mg, ER 40 mg and 60 mg) varies by provincial demand and supplier agreements.
Pharmacies will verify prescriptions and DINs before dispensing to comply with provincial rules.
Online Pharmacy Trends In Canada (Including Provincial Restrictions)
Canadian online pharmacies have increased e-prescribing uptake, making refills and transfers simpler for many patients.
Provincial regulations still require prescription verification and sometimes limit cross‑province shipping of prescription drugs.
Patients ordering online should expect the pharmacy to confirm a valid prescription and DIN before shipping.
Cross‑border purchases from U.S. vendor sites are common for savings but carry regulatory differences in DIN recognition and import rules.
Price Ranges By Package Size (With Provincial Differences)
Out‑of‑pocket cost depends on strength, pack size and whether a provincial drug plan covers the product.
Expect higher personal cost in provinces without generous formularies for nitrates or where a brand rather than generic is dispensed.
| Strength / Pack | In-Store Typical Price | Certified Canadian Online | Cross-Border (US) Estimate |
|---|---|---|---|
| IR 10 mg, 30 tablets | $10–$25 | $8–$20 | $6–$15 |
| IR 20 mg, 30 tablets | $12–$30 | $9–$22 | $7–$18 |
| ER 40 mg, 30 tablets | $20–$45 | $18–$40 | $12–$35 |
| ER 60 mg, 30 tablets | $25–$55 | $20–$48 | $15–$40 |
Provincial modifiers: Ontario (ON) and British Columbia (BC) may have faster formulary adjudication for seniors; Quebec (QC) often has specific pharmacy stocks and supplier arrangements.
Include a visible prescription required badge on product pages to prevent confusion.
Canadian Patient Insights & Satisfaction Levels
Forum And Review Platforms (Reddit Canada, HealthBoards, AskDocs)
Patients in Canadian forums such as r/CanadaHealth and provincial patient groups discuss isosorbide mononitrate frequently for angina prevention.
Threads often compare brand names like Monoket or Ismo and reference dosing differences between IR and ER products.
Online review platforms point to convenience with once‑daily ER products but also stress the need for prescriber follow‑up and pharmacy counselling.
Reported Benefits And Challenges From Canadian Patients
Many patients report fewer angina episodes when a nitrate‑free interval is followed and when ER dosing fits daily routine.
Common complaints include nitrate headaches on initiation and lightheadedness until the dose is adjusted.
- Top patient-reported pros: reduced angina frequency, once‑daily ER convenience, improved adherence.
- Top patient-reported cons: headaches, dizziness, confusion when brands/strengths are switched at the pharmacy.
- Nitrate-Free Interval
- Period of about 10–12 hours with no nitrate exposure to prevent tolerance.
- ER vs IR
- ER = extended release for once‑daily dosing; IR = immediate release for flexible dosing.
Short anonymised patient testimonial for pharmacy pages: “Started ER Monoket 40 mg and noticed fewer chest pains, but the first week gave me headaches — pharmacist advised a 10–12 hour nitrate‑free window and it settled.”
Product Overview & Brand Variants
INN And Brand Names Used In Canada
The INN for Monoket is isosorbide mononitrate, and the product is frequently listed by that name on prescriptions.
International brands include Monoket, Ismo and Imdur, while Canadian supply often comes from generics or imported batches depending on distributor licences.
Commonly encountered strengths worldwide are IR 10 mg and 20 mg and ER 40 mg and 60 mg, which Canadian pharmacies may mirror when available.
Legal Classification Under Health Canada
Isosorbide mononitrate is a prescription‑only medicine in major jurisdictions and requires a valid prescription and, where applicable, a matching DIN for dispensing documentation.
Pharmacy product pages should show DIN when available, the supplier or importer, formulation type and pack sizes to help patients verify what they are receiving.
| Brand | INN | Strengths | Pack Sizes |
|---|---|---|---|
| Monoket | Isosorbide Mononitrate | 10, 20 mg (IR); 40, 60 mg (ER) | Blisters and bottles (20–60 tablets) |
| Generic Imports | Isosorbide Mononitrate | 10–60 mg | Varied by supplier |
Indications In Local Canadian Medical Practice
Approved Uses (Health Canada DIN Context)
Isosorbide mononitrate is indicated primarily for the prevention of angina pectoris as reflected in international labelling and typical DIN‑linked indications.
Standard dosing for prevention includes IR regimens like 20 mg once or twice daily and ER options of 40–60 mg once daily.
The medicine is not intended for acute angina relief; fast‑acting nitroglycerin is the recommended rescue option.
Off-Label Patterns In Canadian Healthcare
Specialists may use isosorbide mononitrate in select off‑label situations such as adjunctive therapy in some heart failure patients, but these uses are clinician‑managed.
| Indication | Approved vs Off-Label | Notes |
|---|---|---|
| Stable Angina | Approved | Prevention; DIN‑linked labelling should be referenced. |
| Chronic Heart Failure | Off-Label (select cases) | Specialist decision, dose adjusted to response. |
Prescribing safeguards: monitor blood pressure, avoid concomitant PDE‑5 inhibitors and document rationale for off‑label use for formulary adjudication.
How It Works In The Body
Layman’s Explanation (Canadian Patient-Friendly Tone)
Isosorbide mononitrate relaxes blood vessel muscle so veins and some arteries widen and the heart does not need to work as hard.
That reduced workload lowers the heart’s oxygen demand and helps reduce the number of angina episodes over time.
Take this as a preventive medicine rather than an instant pain reliever; nitroglycerin is still the rescue spray or tablet for sudden chest pain.
Clinical Detail From Health Canada Resources
Nitrates act as nitric oxide donors leading to vasodilation and reduced preload and afterload on the heart.
Immediate‑release formulations achieve quicker plasma levels while extended‑release products maintain steadier concentrations for once‑daily dosing.
- Vasodilation
- Relaxation of blood vessel smooth muscle to lower cardiac workload.
- Nitrate Tolerance
- Loss of effect over continuous exposure without a nitrate‑free interval.
Clinical recommendation: include a nitrate‑free period of approximately 10–12 hours daily to reduce tolerance risk.
Dosage & Administration
Standard Regimens Per Canadian Guidelines
Standard starting doses reflect international practice: IR often begins at 20 mg once or twice daily, titrating as tolerated to 20–40 mg twice daily.
ER regimens commonly use 40–60 mg once daily to maintain therapeutic concentrations over 24 hours.
Maintain timing and spacing of doses (a minimum ~7‑hour gap between IR doses) and ensure a daily nitrate‑free interval of at least 10–12 hours.
Adjustments By Patient Type (With Canadian Clinical Notes)
| Patient Type | Starting Dose | Monitoring |
|---|---|---|
| Adults | IR 20 mg once; ER 40 mg once daily | BP checks after initiation and after changes |
| Elderly | Start low | Monitor for hypotension and falls |
| Renal/Hepatic Impairment | Use caution | Close monitoring for hypotension |
Do not use in children as safety and efficacy are not established.
Absolute interaction: do not combine with PDE‑5 inhibitors such as sildenafil or tadalafil.
Contraindications & Side Effects
Common (Health Canada-Approved List)
Absolute contraindications include hypersensitivity to nitrates, severe hypotension, acute circulatory failure, and concurrent use of PDE‑5 inhibitors.
Other absolute situations are acute myocardial infarction with low filling pressures, constrictive pericarditis and known severe anemia.
- Very common: headache (nitrate headache).
- Common: dizziness, lightheadedness, flushing.
- Less common: nausea, hypotension.
Rare But Serious (With Canadian Pharmacovigilance Data)
Rare but serious events may include syncope, severe hypotension, tachycardia and allergic rashes.
Patients experiencing fainting, severe lightheadedness or signs of an allergic reaction should seek immediate medical attention.
Serious adverse events should be reported to Health Canada and to provincial adverse reaction reporting systems as part of pharmacovigilance.
Comparable Medicines In Canada
Alternatives Table (With DIN References)
| Drug (INN/Brand) | Class | Common Formulations | Typical Use |
|---|---|---|---|
| Isosorbide Dinitrate (Isoket) | Nitrate | Tablets, spray, IV | Angina prevention/acute in some settings |
| Nitroglycerin (Nitrostat) | Nitrate | Sublingual, patch | Acute relief / prophylaxis |
| Ranolazine (Ranexa) | Metabolic modulator | Oral tablets | Second‑line anti‑anginal |
Pros And Cons List
ER isosorbide mononitrate: pro — once‑daily dosing supports adherence; con — daily headaches and need for nitrate‑free window.
IR formulations: pro — dosing flexibility; con — more frequent dosing and stricter scheduling.
Nitroglycerin: pro — rapid relief for acute angina; con — short duration and not for prophylaxis alone.
Selection between alternatives depends on comorbidities, interaction risk and provincial formulary listings.
Current Research & Trends
Major Canadian Or International Studies 2022–2025
Recent research has focused on strategies to prevent nitrate tolerance, adherence to nitrate‑free intervals and head‑to‑head comparisons of ER versus IR formulations.
Canadian cardiac registries contribute real‑world data on angina management and adverse outcomes linked to nitrates.
International randomized trials and meta‑analyses have examined whether ER formulations offer better adherence with comparable efficacy and side‑effect profiles.
- Recent findings suggest ER dosing can improve adherence but requires careful patient education about nitrate‑free periods.
- Combination therapy with beta‑blockers and nitrates remains a common clinical strategy for refractory angina.
Pharmacy product pages should link to Health Canada safety communications and major trial summaries where available.
Common Patient Questions In Canada
(Use Q&A Style, Pharmacy-Focused)
Q: Is a prescription required in Canada?
A: Yes — isosorbide mononitrate is prescription‑only in major markets and pharmacies will request a valid prescription and confirm DIN where applicable.
Q: Can I use it for acute chest pain?
A: No — use fast‑acting nitroglycerin for an acute attack and call emergency services if pain persists.
Q: What if I experience headaches?
A: Headache is common; starting at a low dose and ensuring a nitrate‑free interval often reduces severity; consult pharmacist or prescriber if persistent.
Q: Are there coverage programs?
A: Coverage varies by province — Ontario Drug Benefit, BC PharmaCare and RAMQ may cover nitrates depending on formulary rules and patient eligibility.
Q: Can I take erectile dysfunction medications with this drug?
A: No — co‑administration with PDE‑5 inhibitors is an absolute contraindication and must be avoided.
Regulatory Status
Health Canada Approval Process
Marketed products for isosorbide mononitrate must meet Health Canada requirements or rely on appropriate regulatory pathways for generics and imports.
Submissions include quality, safety and efficacy data, with post‑market surveillance mandated after approval.
DIN Number Relevance
The Drug Identification Number (DIN) is essential for confirming Health Canada registration, matching product label claims and processing coverage adjudications.
Pharmacy product pages should display the DIN where available and list the manufacturer or importer responsible for the marketed product.
- DIN
- Code that confirms Health Canada registration for a specific formulation, strength and pack.
Visual Recommendations
Infographic Ideas For Canadian Context
Use a clock‑style infographic showing an IR versus ER dosing timeline with a clear 10–12 hour nitrate‑free window.
Include pack icons (blister, bottle) in a table visual for common strengths and sizes.
Feature a prominent safety strip graphic: “Do Not Combine With PDE‑5 Inhibitors.”
Provide a small pricing map or table showing typical in‑store versus online ranges by province and add alt text for accessibility.
Buying & Storage Advice
In-Store Vs. Online Canadian Purchase Tips
Buyers need a valid prescription for dispensing in Canada, and calling ahead to Shoppers, Rexall, London Drugs or Jean Coutu helps confirm stock and strength availability.
Online Canadian pharmacies require e‑prescription validation and often restrict shipping to the same province due to regulatory rules.
Cross‑border purchases can lower cost but risk mismatched DINs and importation irregularities; check labels carefully on arrival.
In our online pharmacy, ismo is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.
Proper Storage With Canadian Climate Considerations
Store products below 25°C (77°F) and protect them from moisture and direct sunlight as per product guidance.
Avoid leaving tablets in hot cars in summer or in freezing conditions during winter transport across Canada.
Keep tablets in original labelled packaging or a clearly labelled pharmacy bottle to avoid confusion during multi‑medication routines.
Guidelines For Proper Use
Canadian Doctor/Pharmacist Advice Style
Take ER formulations at the same time each day and respect the nitrate‑free window of 10–12 hours to avoid tolerance.
Pharmacists should use a patient‑centred counselling script that confirms indication, dosing schedule and screens for PDE‑5 inhibitor use.
Document counselling in the patient record and plan a follow‑up to review blood pressure and angina frequency after initiation or dose change.
Provide a one‑page patient handout that lists common side effects, missed dose guidance and when to call emergency services.
Delivery Across Canada (English)
| City | Region | Delivery Time |
|---|---|---|
| Toronto | Ontario | 5-7 days |
| Montreal | Quebec | 5-7 days |
| Vancouver | British Columbia | 5-7 days |
| Calgary | Alberta | 5-7 days |
| Edmonton | Alberta | 5-7 days |
| Ottawa | Ontario | 5-7 days |
| Winnipeg | Manitoba | 5-7 days |
| Quebec City | Quebec | 5-7 days |
| Halifax | Nova Scotia | 5-7 days |
| Victoria | British Columbia | 5-7 days |
| Hamilton | Ontario | 5-9 days |
| Kitchener | Ontario | 5-9 days |
| London | Ontario | 5-9 days |
| Saskatoon | Saskatchewan | 5-9 days |
| Regina | Saskatchewan | 5-9 days |
Final Practical Notes
Label clarity matters: display the DIN, strength and whether the product is IR or ER on the product page so patients confirm what they receive.
Counselling checklist items should include nitrate‑free interval timing, expected side effects like headaches and the absolute ban on PDE‑5 inhibitors.
Report any serious adverse events to Health Canada and the local provincial reporting system to support pharmacovigilance.
When switching brands or formulations, pharmacists should provide stepwise counselling and a printout showing the new dosing schedule to avoid confusion during the transition.